cover image: BMC Submission on Potential Pan-Canadian Formulary (February 25, 2022)

20.500.12592/xdtx0z

BMC Submission on Potential Pan-Canadian Formulary (February 25, 2022)

1 Mar 2022

Refine and Clarify Goal and Principles: Enshrine improved care and best possible patient outcomes as core objectives • The stated goal of a potential Pan-Canadian Formulary, as developed by the Advisory Panel, includes important elements such as providing a broad-range of safe and effective drugs and meeting the health care needs of Canada’s diverse population. [...] 2 www.bestmedicinescoalition.org Consistency and cohesion: The introduction of a potential Pan-Canadian Formulary needs to be considered in conjunction with other suggested changes to the pharmaceutical care framework in Canada, including the creation of a Canadian Drug Agency, a National Strategy for Drugs for Rare Diseases, health technology assessment and management and proposed changes to pric. [...] Patient informed policy development: Patients and the organizations that represent them must continue to play an integral role and that role must be enhanced during the development and integration of pharmaceutical care policies, including the development of a potential Pan-Canadian Formulary. [...] The range of medications covered must meet the individual needs of all, regardless of type of condition, whether acute and chronic, or incidence/rareness of disease, including the realm of precision medicine. [...] It is imperative that implementation of a potential formulary support the goal of improving access and patient outcomes and that it do so in a meaningful and measurable way.
Pages
6
Published in
Canada